Pulmonary NTM: what, who, when , how

“The quality of what Pharmacy Management is putting on is simply streets ahead of anything else I’m seeing at the moment. Keep up the good work!”
Noel Wicks, Managing Director, Right Medicine Pharmacy Ltd, Stirling
Satellite Pulmonary NTM: what, who, when , how
Speakers Prof Michael Loebinger
Satellite Description

NTM is increasing in incidence, and a result pharmacists will see more of it presenting across primary and secondary care. It affects patients with a wide variety of respiratory comorbidities; including COPD, CF, and bronchiectasis.

This session will help pharmacists understand the NTM epidemiology, the rationale for different therapies, who needs treating, and how they can support patients with NTM.

Professor Michael Loebinger is Professor of Practice (Respiratory Medicine) at Imperial and Consultant Respiratory Physician at Royal Brompton. He co-chaired the British Thoracic Society (BTS) Bronchiectasis Guidelines and co-wrote the BTS NonTuberculous Mycobacteria (NTM) and European Respiratory

Society (ERS) Bronchiectasis Guidelines.  He is a founding member of the UK and European Clinical and Research Bronchiectasis and NTM networks.

‘This session is organised and sponsored by Insmed Ltd’

 

Sponsored By Insmed

Back to Course

Website by MAXX Design

© 2020 Pharman | All rights reserved | Site Map | Accessibility | Privacy and Cookie Policy | Terms & Conditions

Confirmation

This site is intended for healthcare professionals or people employed in the pharmaceutical industry. Please confirm that you are such a person.

Continue